跳至主要内容
临床试验/NCT01906112
NCT01906112撤回3 期

Role of Surgery for the Primary in Patients With Breast Cancer Stage IV - A Prospective Randomized Multicenter Controlled Trial

National Cancer Institute, Thailand9 个研究点 分布在 1 个国家开始时间: 2013年8月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
撤回
发起方
试验地点
9
主要终点
Overall survival

研究概览

简要总结

The purpose of this study is to determine benefits of surgery for the primary in patients with breast cancer stage IV in randomized controlled study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者
是

入选标准

  • •Healthy breast cancer stage IV patients with resectable primary breast tumor.
  • •Resectable breast cancer stage IV patients who well response of visceral metastasis to systemic therapy and fit for surgery.

排除标准

  • •Breast cancer stage IV patients with local complication of primary breast tumor that require surgery for palliation such as uncontrolled bleeding,large and non-healing ulcer or intractable pain.
  • •Breast cancer stage IV patients with unresectable primary breast tumor or extensive chest wall disease.

研究组 & 干预措施

Controlled

No Intervention

No surgery for primary breast tumor.

Study

Experimental

Surgery for primary breast tumor.

干预措施: Surgery for primary breast tumor. (Procedure)

结局指标

主要结局

Overall survival

时间窗: Five years

次要结局

  • Quality of life & Uncontrolled chest wall disease(Five years)

研究者

发起方
National Cancer Institute, Thailand
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

AKANIST PIYAPANT, MD.,FRCST.

Surgical Oncologist.

National Cancer Institute, Thailand

研究点 (9)

Loading locations...

相似试验

Role of Surgery for the Primary in Patients With... | 临床试验